Latest News & Features
Americas
Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis. 14 November 2018
Americas
Gene-editing company CRISPR Therapeutics has expanded its partnership with US-based MaxCyte, which focuses on cell-based medicines, into the immuno-oncology arena. 13 November 2018
Big Pharma
Associations representing the pharmaceutical and biotechnology fields have said that the UK should maintain “close cooperation” with the EU post-Brexit, to ensure that access to safe and effective medicines continues in both markets. 12 November 2018
Africa
Jordan-based Hikma Pharmaceuticals and British pharmaceutical company Vectura Group have united to develop generic versions of GSK’s Ellipta respiratory products. 12 November 2018
Americas
A jury has said that Flexus Biosciences, a company owned by Bristol-Myers Squibb, does not need to pay damages despite being liable for trade secrets misappropriation. 12 November 2018
Americas
The strongest cannabidiol patent portfolios are owned by Roche, Boehringer Ingelheim, and AbbVie, according to a report released earlier this week. 9 November 2018
Biotechnology
The European Patent Office has revoked a Bayer-owned patent which covers a type of broccoli adapted to make their harvesting easier. 9 November 2018
Americas
Biotech company Momenta has obtained the rights to use AbbVie’s Humira IP, enabling the global commercialisation of Momenta’s proposed Humira biosimilar, M923. 8 November 2018
Big Pharma
The Swiss Federal Institute of Intellectual Property has issued a notice covering a change in the practice for granting supplementary protection certificates (SPCs), following a landmark decision by Switzerland’s highest court. 8 November 2018
Americas
Womble Bond Dickinson has strengthened its Boston-based life sciences team with the addition of patent attorney Briana Erickson. 7 November 2018